Cargando…

FDG-PET in colorectal cancer

[(18)F]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is a useful imaging tool in the evolving management of patients with colorectal carcinoma. This technique is able to measure and visualize metabolic changes in cancer cells. This feature results in the ability to distinguish viable t...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Geus-Oei, Lioe-Fee, Ruers, Theo J M, Punt, Cornelis J A, Willem Leer, Jan, Corstens, Frans H M, Oyen, Wim J G
Formato:	Texto
Lenguaje:	English
Publicado:	e-MED 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805073/ https://www.ncbi.nlm.nih.gov/pubmed/17114081 http://dx.doi.org/10.1102/1470-7330.2006.9014

Ejemplares similares

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Methodological considerations in quantification of oncological FDG PET studies
por: Vriens, Dennis, et al.
Publicado: (2009)

FDG-PET/CT based response-adapted treatment
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2012)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Colorectal cancer: the role of PET/CT in recurrence: Wednesday 5 October 2005, 14:00–16:00
por: Vogel, Wouter V, et al.
Publicado: (2005)

FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2022)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer
por: Heijmen, Linda, et al.
Publicado: (2015)

A comparison of the diagnostic value of MRI and (18)F-FDG-PET/CT in suspected spondylodiscitis
por: Smids, Carolijn, et al.
Publicado: (2016)

Editorial on Special Issue “Quantitative PET and SPECT”
por: van Velden, Floris H. P., et al.
Publicado: (2022)

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours
por: Dijkman, Bernadette G., et al.
Publicado: (2010)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

Optimal respiratory-gated [(18)F]FDG PET/CT significantly impacts the quantification of metabolic parameters and their correlation with overall survival in patients with pancreatic ductal adenocarcinoma
por: Smeets, Esther M. M., et al.
Publicado: (2019)

The diagnostic value of (18)F–FDG-PET/CT and MRI in suspected vertebral osteomyelitis – a prospective study
por: Kouijzer, Ilse J. E., et al.
Publicado: (2017)

[(18)F]FDG Uptake and Expression of Immunohistochemical Markers Related to Glycolysis, Hypoxia, and Proliferation in Indeterminate Thyroid Nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Prognostic Value of Quantitative [(18)F]FDG-PET Features in Patients with Metastases from Soft Tissue Sarcoma
por: Kalisvaart, Gijsbert M., et al.
Publicado: (2021)

The Value of (18)F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
por: Bijlstra, Okker D., et al.
Publicado: (2022)

Investigating the potential added value of [(18)F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study
por: Chen, Linda L., et al.
Publicado: (2023)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring (18)F-FDG-PET/CT
por: Meijer, Tineke W.H., et al.
Publicado: (2018)

Adding the temporal domain to PET radiomic features
por: Noortman, Wyanne A., et al.
Publicado: (2020)

Evaluation of FDG-PET/CT Use in Children with Suspected Infection or Inflammation
por: Ropers, Fabienne G., et al.
Publicado: (2020)

A clinically applicable molecular classification of oncocytic cell thyroid nodules
por: de Koster, Elizabeth J, et al.
Publicado: (2023)

(18)F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study
por: Carvalho, Sara, et al.
Publicado: (2018)

Nanocarriers as a Tool for the Treatment of Colorectal Cancer
por: C. de S. L. Oliveira, Ana Luiza, et al.
Publicado: (2021)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [(18)F]-FDOPA PET/CT study
por: Schalbroeck, Rik, et al.
Publicado: (2021)

PET imaging during hypoglycaemia to study adipose tissue metabolism
por: Boss, Marti, et al.
Publicado: (2019)

Denosumab Reduces Lesional Fluoride Skeletal Burden on Na[(18)F]F PET-CT in Patients With Fibrous Dysplasia/McCune–Albright Syndrome
por: van der Bruggen, Wouter, et al.
Publicado: (2021)

Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients
por: Bulten, Ben F., et al.
Publicado: (2015)

Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[(18)F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
por: Vaz, Sofia C., et al.
Publicado: (2022)

Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[(18)F]FDG-PET/CT external beam radiation treatment planning in lung cancer
por: Vaz, Sofia C., et al.
Publicado: (2022)

Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[(18)F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
por: Vaz, Sofia C., et al.
Publicado: (2022)

Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations
por: van Dalen, Jorn A., et al.
Publicado: (2007)

Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas
por: Kleiburg, Fleur, et al.
Publicado: (2023)

Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery
por: Stammes, Marieke A., et al.
Publicado: (2017)

Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021)

FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer
por: Arens, Anne I. J., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fuqh9c8i5hr32ud2oa0qebseth